Currently out of the existing stock ratings of Martin Fan, 17 are a BUY (85%), 3 are a HOLD (15%).

Martin Fan

Work Performance Price Targets & Ratings Chart

Analyst Martin Fan, currently employed at WEDBUSH, carries an average stock price target met ratio of 42.5% that have a potential upside of 42.79% achieved within 46 days.

Martin Fan’s has documented 40 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RNAC, Cartesian Therapeutics at 18-Aug-2026.

Wall Street Analyst Martin Fan

Analyst best performing recommendations are on SANA (SANA BIOTECHNOLOGY).
The best stock recommendation documented was for SANA (SANA BIOTECHNOLOGY) at 9/24/2025. The price target of $5 was fulfilled within 21 days with a profit of $1.59 (46.63%) receiving and performance score of 22.2.

Average potential price target upside

of $16.4 (126.31%) on ORKA (ORUKA THERAPEUTICS).
of $16.34 (67.85%) on ANAB (ANAPTYSBIO).

ANAB AnaptysBio ARTV Artiva Biotherapeutics, Common Stock ORKA Oruka Therapeutics RNAC Cartesian Therapeutics SANA Sana Biotechnology VOR Vor Biopharma

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Yasmeen Rahimi (PIPER SANDLER)